Analysis of key recent licensing and partnership agreements in Unstable Angina
Of all candidate laboratory and clinical predictors, unstable angina
was associated primarily with increased CRP (Table 3).
For more information, the British Cardiac Patients' Association has a 9-5pm helpline on unstable angina
Clinical Practice Guideline Number 10: Diagnosing and Managing Unstable Angina
First, the guideline's recommendation to pursue outpatient management for low-risk unstable angina
patients represents a departure from current clinical practice.
Frei suggests that a patient with unstable angina
pectoris or coronary heart disease might be prudent to take up to a 500-mg supplement of vitamin C daily.
Currently, aspirin and a blood thinner called heparin are the mainstays of treatment for unstable angina
1 List of Tables and Figures 2 Unstable Angina
Therapeutics - Introduction 3 Unstable Angina
Therapeutics - Market Characterization 4 Unstable Angina
Therapeutics - Competitive Assessment 5 Unstable Angina
Therapeutics - Pipeline Assessment 6 Unstable Angina
Therapeutics - Clinical Trials Mapping 7 Unstable Angina
Therapeutics - Strategic Assessment 8 Unstable Angina
Therapeutics - Future Players 9 Unstable Angina
Therapeutics - Licensing & Partnership Deals 10 Unstable Angina
Therapeutics - Appendix
The report provides information on the key drivers and challenges of the Unstable Angina
The double-blind, randomized study found that, when compared with heparin (the indirect thrombin inhibitor currently considered standard treatment), the direct thrombin inhibitor Refludan had a greater reduction in the combination of cardiac death or new heart attacks and decreased the need for invasive procedures in patients experiencing unstable angina
25 /PRNewswire/ -- Lepirudin (Refludan(TM), Hoechst Marion Roussel) produces reductions in death, heart attack and need for invasive cardiac procedures compared to the current standard treatment in patients experiencing unstable angina
RPR is seeking marketing clearance for Lovenox/Clexane to be administered with aspirin in the treatment of patients with unstable angina
and non-Q-wave myocardial infarction.